319 related articles for article (PubMed ID: 25816748)
1. Triggering receptor expressed on myeloid cells-2 is involved in prion-induced microglial activation but does not contribute to prion pathogenesis in mouse brains.
Zhu C; Herrmann US; Li B; Abakumova I; Moos R; Schwarz P; Rushing EJ; Colonna M; Aguzzi A
Neurobiol Aging; 2015 May; 36(5):1994-2003. PubMed ID: 25816748
[TBL] [Abstract][Full Text] [Related]
2. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
[TBL] [Abstract][Full Text] [Related]
3. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
Neumann H; Takahashi K
J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
[TBL] [Abstract][Full Text] [Related]
4. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
[TBL] [Abstract][Full Text] [Related]
5. TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson's disease.
Zhang Y; Feng S; Nie K; Li Y; Gao Y; Gan R; Wang L; Li B; Sun X; Wang L; Zhang Y
Biochem Biophys Res Commun; 2018 May; 499(4):797-802. PubMed ID: 29621548
[TBL] [Abstract][Full Text] [Related]
6. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
Lue LF; Schmitz C; Walker DG
Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
[TBL] [Abstract][Full Text] [Related]
7. TREM2 expression in the brain and biological fluids in prion diseases.
Diaz-Lucena D; Kruse N; Thüne K; Schmitz M; Villar-Piqué A; da Cunha JEG; Hermann P; López-Pérez Ó; Andrés-Benito P; Ladogana A; Calero M; Vidal E; Riggert J; Pineau H; Sim V; Zetterberg H; Blennow K; Del Río JA; Marín-Moreno A; Espinosa JC; Torres JM; Sánchez-Valle R; Mollenhauer B; Ferrer I; Zerr I; Llorens F
Acta Neuropathol; 2021 Jun; 141(6):841-859. PubMed ID: 33881612
[TBL] [Abstract][Full Text] [Related]
8. TREM2 Promotes Microglial Survival by Activating Wnt/β-Catenin Pathway.
Zheng H; Jia L; Liu CC; Rong Z; Zhong L; Yang L; Chen XF; Fryer JD; Wang X; Zhang YW; Xu H; Bu G
J Neurosci; 2017 Feb; 37(7):1772-1784. PubMed ID: 28077724
[TBL] [Abstract][Full Text] [Related]
9. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
10. TREM2 sustains microglial expansion during aging and response to demyelination.
Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
[TBL] [Abstract][Full Text] [Related]
11. Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice.
Jiang T; Tan L; Zhu XC; Zhou JS; Cao L; Tan MS; Wang HF; Chen Q; Zhang YD; Yu JT
Neurobiol Aging; 2015 Dec; 36(12):3176-3186. PubMed ID: 26364736
[TBL] [Abstract][Full Text] [Related]
12. TREM2 in CNS homeostasis and neurodegenerative disease.
Painter MM; Atagi Y; Liu CC; Rademakers R; Xu H; Fryer JD; Bu G
Mol Neurodegener; 2015 Sep; 10():43. PubMed ID: 26337043
[TBL] [Abstract][Full Text] [Related]
13. Triggering receptor expressed on myeloid cells 2 (TREM2) dependent microglial activation promotes cisplatin-induced peripheral neuropathy in mice.
Hu LY; Zhou Y; Cui WQ; Hu XM; Du LX; Mi WL; Chu YX; Wu GC; Wang YQ; Mao-Ying QL
Brain Behav Immun; 2018 Feb; 68():132-145. PubMed ID: 29051087
[TBL] [Abstract][Full Text] [Related]
14. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
[TBL] [Abstract][Full Text] [Related]
15. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2).
Zhong L; Wang Z; Wang D; Wang Z; Martens YA; Wu L; Xu Y; Wang K; Li J; Huang R; Can D; Xu H; Bu G; Chen XF
Mol Neurodegener; 2018 Mar; 13(1):15. PubMed ID: 29587871
[TBL] [Abstract][Full Text] [Related]
17. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
18. Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
Okuzono Y; Sakuma H; Miyakawa S; Ifuku M; Lee J; Das D; Banerjee A; Zhao Y; Yamamoto K; Ando T; Sato S
FEBS Open Bio; 2021 Nov; 11(11):3063-3080. PubMed ID: 34523252
[TBL] [Abstract][Full Text] [Related]
19. The role of TREM2 in Alzheimer's disease; evidence from transgenic mouse models.
Karanfilian L; Tosto MG; Malki K
Neurobiol Aging; 2020 Feb; 86():39-53. PubMed ID: 31727362
[TBL] [Abstract][Full Text] [Related]
20. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]